Pavelek, Z.; Angelucci, F.; Souček, O.; Krejsek, J.; Sobíšek, L.; Klímová, B.; Šarláková, J.; Halúsková, S.; Kuča, K.; Vališ, M.
Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase. J. Clin. Med. 2020, 9, 1468.
https://doi.org/10.3390/jcm9051468
AMA Style
Pavelek Z, Angelucci F, Souček O, Krejsek J, Sobíšek L, Klímová B, Šarláková J, Halúsková S, Kuča K, Vališ M.
Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase. Journal of Clinical Medicine. 2020; 9(5):1468.
https://doi.org/10.3390/jcm9051468
Chicago/Turabian Style
Pavelek, Zbyšek, Francesco Angelucci, Ondřej Souček, Jan Krejsek, Lukáš Sobíšek, Blanka Klímová, Jana Šarláková, Simona Halúsková, Kamil Kuča, and Martin Vališ.
2020. "Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase" Journal of Clinical Medicine 9, no. 5: 1468.
https://doi.org/10.3390/jcm9051468
APA Style
Pavelek, Z., Angelucci, F., Souček, O., Krejsek, J., Sobíšek, L., Klímová, B., Šarláková, J., Halúsková, S., Kuča, K., & Vališ, M.
(2020). Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase. Journal of Clinical Medicine, 9(5), 1468.
https://doi.org/10.3390/jcm9051468
